All News

price%20dollar%20pill.jpg

Abuse of the Safety-Net 340B Drug Programs

Jack Cush, MD

Dr. Madelaine Feldman has written an important commentary on the 340B Drug Pricing Program, a safety-net program that would allow vulnerable populations to receive expensive new therapies. But she points out that "this well-intentioned program has strayed from its original purpose", allowing certain hospitals and for-profit pharmacies to exploit the program.

Read Article
question mark

ICYMI: Are Emulation Trials a Fantasy?

Janet Pope, MD, MPH, FRCPC

Are emulation ‘trials’ helpful, despite the biases that occur with observational data, or do they truly mimic the results of randomized controlled trials (RCTs)?

Read Article
RheumNow Podcast square

54K Peptic Ulcers Annually (12.13.2024)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com

Read Article
young%20doctors.jpg (keep)

Way Behind in Pediatric Rheumatology

Jack Cush, MD

While adult rheumatology fellowships have surged in popularity and become quite competitive, more than half of pediatric rheumatology fellowship positions went unfilled in 2024, according to the National Resident Matching Program (NRMP). 

Read Article
GCA,woman

ICYMI: SELECT-GCA suggests JAKis may be the new kid on the block

Mrinalini Dey, MD

Clinicians treating giant cell arteritis (GCA) have long had to contend with a disappointingly limited selection of drugs from which to select. A new group of drugs is finally showing promise in the treatment of GCA.

Read Article
RheumNow Podcast square

Don’t Buy Guitars (12.6.2024)

Jack Cush, MD

This year at ACR24, the RheumNow faculty and reporters were prolific, generating >800 Tweets, 56 written articles, 117 Videos and 28 podcasts – all in 4 days! You can best review and learn ACR24 by A) Rheumatology Roundup; b) Topic Panel videos; and c) Topic podcasts.

Read Article
ICYMI: Are Emulation Trials a Fantasy? https://t.co/eCO8a1UFlB https://t.co/PPczmxYFKa

Links:

Dr. John Cush RheumNow ( View Tweet)
Join us at RheumNow Live February 8 & 9 in Dallas, TX! Our incredible meeting will feature speakers like: Rheumatology Power Trio: Exploring RA Management in Older Adults, AI Innovations, and Multimorbidity Strategies Una Makris, MD, MSc Jeff Curtis, MD, MS, MPH Bryant… https://t.co/570WrI6RHT https://t.co/TTGtcNmWx7
Dr. John Cush RheumNow ( View Tweet)
2024 Match results are in - Rheumatology- 287 matched, 99%: Top 6: 1. Cardi 99.8% 2. Cardio EP 98% 3. Endocrinology 98.4 % 4. GI 99.6% 5. Heme/Onc 99.7% 6. Rheum 99% https://t.co/UYnXc13VvQ https://t.co/kAZ4GACXkL

Links:

Dr. John Cush RheumNow ( View Tweet)
Predicting Flares in Rheumatoid Arthritis Dr. Jonathan Kay interviews Dr. John Isaacs about abstract 1349, presented at the 2024 ACR Convergence meeting in Washington, DC. https://t.co/pM1AgPiRla https://t.co/0hP5y1JgPq

Links:

Dr. John Cush RheumNow ( View Tweet)
Sex Differences in Psoriatic Arthritis Dr. Catherine Bakewell shared key takeaways from a session presented Sunday morning by Dr. Laura Coates and Dr. Lihi Eder, as well as abstract 1709. https://t.co/eKAzPSDQLH https://t.co/ACYMgVSW89

Links:

Dr. John Cush RheumNow ( View Tweet)
Way Behind in Pediatric Rheumatology While adult rheumatology fellowships have surged in popularity and become quite competitive, more than half of pediatric rheumatology fellowship positions went unfilled in 2024, according to the National Resident Matching Program (NRMP).… https://t.co/O03bA0xWL8 https://t.co/vJYKgyYNwI
Dr. John Cush RheumNow ( View Tweet)
Don’t Buy Guitars (12.6.2024) This year at ACR24, the RheumNow faculty and reporters were prolific, generating >800 Tweets, 56 written articles, 117 Videos and 28 podcasts – all in 4 days! You can best review and learn ACR24 by A) Rheumatology Roundup; b) Topic Panel videos;… https://t.co/iaoykvKoCH https://t.co/e0pELS3hMu
Dr. John Cush RheumNow ( View Tweet)
ACR24 IL-17 Panel Join Dr. Philip Mease, Dr. Brian Jaros and Dr. Peter Nash as they discuss key takeaways on IL-17 presentations and data presented at the 2024 ACR Convergence meeting in Washington, DC. https://t.co/04bW7vaMTQ https://t.co/0rTglbW75u

Links:

Dr. John Cush RheumNow ( View Tweet)
Navigating Rheumatology Care in Humanitarian Crisis Settings Dr. Antoni Chan talks with Dr. Martha Dhzhus, who presented Thursday at the Global Summit about rheumatology care in the Ukraine, at the 2024 ACR Convergence meeting in Washington, DC. https://t.co/k4YTVFnTiF https://t.co/bScrJ28rKi

Links:

Dr. John Cush RheumNow ( View Tweet)
Challenge in Measuring Cutaneous Lupus Activity and Severity JAMA Dermatology features a discussion by Drs. McMichael and Frey on measuring lupus skin disease in clinical trials and practice using the validated Cutaneous Lupus Erythematosus Disease Area and Severity Index… https://t.co/qyZPDzUduO https://t.co/cCoc3sWCJy
Dr. John Cush RheumNow ( View Tweet)
BMJ has published an extensive, full read review of the Advances in the management of psoriatic arthritis in adults - by Drs. Gladman and Kharouf, (great read and reference!) https://t.co/4Bz3Vq93jH https://t.co/ZhwKZ4XmNy

Links:

Dr. John Cush RheumNow ( View Tweet)
JAMA FULL READ review and overview of Axial Spondyloarthritis by Drs. Deodhar & Bittar - Dx often delayed 6-8 yrs - Sensitivity/Specificity of: HLA-B27 (50%/90%), CRP (35%/91%), Xray sacroiliitis (66%/68%) or MRI (78%/88%). Great tables, figs, Xrays &Reference!… https://t.co/UbqVOr2iDx https://t.co/Ye5mYcbYX2
Dr. John Cush RheumNow ( View Tweet)
ACR24 JAK TYK Topic Panel https://t.co/SzurEICVxr https://t.co/m6cKyA4BBv

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Improving the Value of Musculoskeletal Ultrasound in Rheumatology Care MSUS has emerged as a powerful asset in rheumatology, providing a real-time, non-invasive, and cost-effective solution for diagnosing and managing inflammatory arthritis conditions such as RA and PsA.… https://t.co/94i7NZGSJH https://t.co/XiSLNaLuf9
Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×